Costotransverse Foramen Block Versus Thoracic Paravertebral Block in Thoracotomy for Lung Cancer
Recruiting · NCT07367581 · Interventional (participants receive a specific treatment) · Lead sponsor: National Cancer Institute, Egypt
View the official record on ClinicalTrials.gov →Interventions studied
Costotransverse foramen blockThoracic paravertebral plane block
What this trial is about
This study aims to compare the costotransverse foramen block (CTFB) with thoracic paravertebral block (TPVB) in patients undergoing thoracotomy for lung cancer.
Who can take part
Age range
18 Years to 65 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Age \> 18 years and ≤ 65 years old.
- American Society of Anesthesiologists (ASA) physical status II-III.
- Body mass index 18-35 kg/m2.
- Patients scheduled for thoracotomies for lung cancer.
Exclusion criteria
- Patient refusal.
- History of sensitivity to local anesthetics.
- History of psychological disorders.
- Contraindication to regional anesthesia, e.g., local sepsis, pre-existing peripheral neuropathies, and coagulopathy.
- Severe respiratory, cardiac, hepatic, or renal disease.
- Morbid obesity.
- Uncooperative patients.
- Patients on chronic pain therapy.
Where it is running
1 location listed.
- Cairo University - Cairo, Egypt